PRESS RELEASE published on 02/04/2025 at 14:03, 1 year 8 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares total shares and voting rights. Announcement confirms 97,330,405 shares and 165,560,444 voting rights as of Jan 1, 2025 Voting Rights Capital Shares Sartorius Stedim Biotech SA Announcement
BRIEF published on 01/29/2025 at 12:31, 1 year 9 months ago Sartorius Stedim Biotech: Preliminary Results 2024 EBITDA Sartorius Turnover Results 2024 Outlook 2025
BRIEF published on 01/28/2025 at 07:09, 1 year 9 months ago Sartorius Stedim Biotech Reveals Preliminary 2024 Financial Results Profitability Order Intake Sartorius Stedim Biotech Sales Revenue Financial Results 2024
PRESS RELEASE published on 01/28/2025 at 07:04, 1 year 9 months ago Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2024 Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2024, meeting revenue and profitability targets. Cautiously positive outlook for 2025 with profitable growth expected Financial Results Sartorius Stedim Biotech Profitable Growth Outlook 2024
BRIEF published on 01/07/2025 at 10:18, 1 year 9 months ago Half-yearly report on the liquidity contract of Sartorius Stedim Biotech Liquidity Contract Transactions Kepler Cheuvreux Half-yearly Report Sartorius Stedim Biotech
PRESS RELEASE published on 01/07/2025 at 10:13, 1 year 9 months ago Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech Sartorius Stedim Biotech S.A. releases half-year liquidity contract statement with details of shares and executed trades, complying with AMF regulations Liquidity Contract Shares Traded Volume Sartorius Stedim Biotech AMF Regulations
BRIEF published on 01/06/2025 at 11:08, 1 year 9 months ago Number of shares and voting rights of Sartorius Stedim Biotech Share Capital Voting Rights Actions AMF Sartorius Stedim Biotech
PRESS RELEASE published on 01/06/2025 at 11:03, 1 year 9 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech S.A. in Aubagne, France declares the total number of shares and voting rights in their issued capital according to regulations Voting Rights Shares Sartorius Stedim Biotech France Aubagne
PRESS RELEASE published on 01/06/2025 at 11:03, 1 year 9 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the number of shares and voting rights in their issued capital as of December 31, 2024 Voting Rights Capital Déclaration Shares Sartorius Stedim Biotech
BRIEF published on 12/03/2024 at 10:43, 1 year 10 months ago Sartorius Stedim Biotech Statement on Share Capital Share Capital Voting Rights Actions AMF Sartorius Stedim
Published on 10/30/2026 at 23:35, 1 day 4 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 1 day 4 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 1 day 9 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 1 day 12 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/31/2026 at 16:35, 11 hours 41 minutes ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 1 day 5 hours ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 18:38, 1 day 9 hours ago EQS-Adhoc: Starcom Holding AD publishes Interim Q3 2026 Financial Report
Published on 10/30/2026 at 23:00, 1 day 5 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 12:00, 1 day 16 hours ago Capital increase through exercise of subscription rights
